The effect of cardiovascular diseases on the course of multiple sclerosis (review of literature)

Por N. A. Neofidov, N. A. Totolyan, M. V. Shumilina, A. A. Skoromets, E. P. Evdoshenko
Publicado em 2020-02-01

The relationship of the brainstem ischemia and chronicity of lumboischialgia

Por D. G. Smolko, K. T. Aliev, E. V. Bondarenko, D. A. Lobatsevich, O. T. Makarova, G. V. Ponomarev, M. V. Shumilina
Publicado em 2015-09-01

Recommendations from the Expert Meeting «Secondary progressive multiple sclerosis: unresolved issues and prospects»

Por N. V. Khachanova, A. N. Boyko, K. Z. Bakhtiyarova, Ya. V. Vlasov, E. P. Evdoshenko, S. A. Sivertseva, T. E. Schmidt, M. V. Shumilina
Publicado em 2019-12-01

Clinical recommendations for the use of ocrelizumab in patients with multiple sclerosis

Por A. N. Boyko, M. V. Davydovskaya, N. V. Khachanova, M. N. Zakharova, N. N. Spirin, E. V. Popova, V. M. Alifirova, Ya. V. Vlasov, S. A. Sivertseva, F. A. Khabirov, M. V. Shumilina, E. P. Evdoshenko
Publicado em 2019-11-01

Recommendations for the use of cladribine tablets for the pathogenetic treatment of patients with highly active multiple sclerosis

Por K. Z. Bakhtiyarova, A. N. Boyko, Ya. V. Vlasov, Z. A. Goncharova, M. V. Davydovskaya, M. N. Zakharova, N. A. Malkova, A. I. Nilov, S. A. Sivertseva, N. N. Spirin, N. A. Totolyan, F. A. Khabirov, M. V. Shumilina
Publicado em 2020-06-01